Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Antidepressant

or Stimulant

or [[:Category:Antioxidants|Antioxidant]]

Use the filters below to narrow your results.

None (43) · Anafranil (1) · Aurorix (1) · Benzedrex (1) · Cymbalta, Drizalma Sprinkle, Irenka, Yentreve (1) · Edronax (1) · Fetzima (1) · Generic; huge OTC presence (1) · Generic; many OTC formulations (1) · Ludiomil (1) · Marplan (1) · Nardil (1) · Norpramin (1) · Parnate (1) · Savella (1) · Serzone (1) · Stablon (1) · Surmontil (1) · Tofranil (1) · Valdoxan (1) · Vivactil (1) · Zoloft (1)

Monoamine releasing agent (8) · Dopamine/norepinephrine reuptake inhibitor (5) · Selective norepinephrine reuptake inhibitor (4) · Irreversible non-selective MAO inhibitor (3) · Serotonin and norepinephrine reuptake inhibitor (3) · None (2) · Cathinone analogue; monoamine reuptake inhibitor (2) · Dopamine and norepinephrine reuptake inhibitor (2) · Norepinephrine–dopamine reuptake inhibitor (2) · Serotonin–norepinephrine reuptake inhibitor (2)

Other values:

None (61) · Depression, anxiety, neuropathic pain, fibromyalgia, chronic musculoskeletal pain (1) · '"`UNIQ--vote-000012CE-QINU`"', '"`UNIQ--vote-000012CF-QINU`"', '"`UNIQ--vote-000012D0-QINU`"' (1) · '"`UNIQ--vote-000012E5-QINU`"', '"`UNIQ--vote-000012E6-QINU`"', '"`UNIQ--vote-000012E7-QINU`"', '"`UNIQ--vote-000012E8-QINU`"' (1)

None (61) · 25 mg (1) · General supplementation 75-90 mg/d (RDA); scurvy treatment 100-1000 mg/d for several weeks; megadose claims unsupported (1) · Replacement: 15-30 mg (22.5-45 IU) daily; NASH: 800 IU daily; AREDS-2: 400 IU daily (in combination formula) (1)

None (61) · 100, 200, 400 IU softgels and capsules; many proprietary OTC blends; combined formulations (AREDS-2) (1) · 100, 250, 500, 1000 mg tablets, chewables, gummies, effervescent; IV (specialty) (1) · 25 mg, 50 mg, 100 mg tablets; oral concentrate 20 mg/mL (1)

None (61) · 200 mg/d (1) · UL 1000 mg (~1500 IU natural)/d in adults; routinely exceeded in older AREDS-1 trials (1) · UL 2000 mg/d in adults (1)

None (60) · IV (1) · Oral (4)

None (60) · Anxiolysis classically 3-4 weeks, continuing improvement to 8-12 weeks (1) · Days for symptom improvement in scurvy (1) · Days to weeks for tissue saturation (1) · Mood: 2–4 weeks. Pain: often within 1–2 weeks. (1)

None (60) · Chronic daily dosing (1) · Hours (1) · Long (1) · Weeks (fat-soluble) (1)

None (60) · ~10-20 days (steady-state body pool); single dose plasma ~2 hours (1) · ~12 hours (1) · ~26 h (sertraline; range 13-45 h, longer in females); ~62-104 h (N-desmethylsertraline, weakly active) (1) · ~3-4 days plasma; adipose tissue stores last months (1)

None (60) · Absolute bioavailability not precisely characterized; food modestly increases exposure (1) · High with fat-containing meal; reduced in malabsorption (1) · ~50% (highly variable) (1) · ~70-90% at typical doses; saturable at high doses (>500 mg) (1)

None (60) · Category C (1) · Category C'"`UNIQ--ref-0000008F-QINU`"' (1) · Safe at replacement doses; high-dose use generally avoided.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) · Safe at routine doses; routinely supplemented in pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)

None (60) · OTC in US (2) · Rx-only (1) · Rx-only in US (1)

Showing below up to 64 results in range #1 to #64.

2

3

4

A

B

Bromantane

C

Cyclazodone

D

E

H

Hexedrone

I

L

Levomilnacipran

M

N

N-Ethylhexedrone

P

R

S

Sertraline

T

V

Vitamin E

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"